Pharmacokinetic and Safety Evaluation of BILR 355, a Second-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers

BILR 355 is a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) under clinical development for the treatment of human immunodeficiency virus infection, particularly in those who harbor virus resistant to the currently available NNRTIs. Two single-center, double-blinded, placebo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Huang, Fenglei, Koenen-Bergmann, Michael, MacGregor, Thomas R., Ring, Arne, Hattox, Susan, Robinson, Patrick
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2008
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2592860/
https://ncbi.nlm.nih.gov/pubmed/18824608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00363-08
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados